Ensartinib dihydrochloride
CAS No. | 2137030-98-7 | Cat. No. | BCP29059 |
Name | Ensartinib dihydrochloride | ||
Synonyms | X396; X-396; X 396;X-396 hydrochloride; | ||
Formula | C26H29Cl4FN6O3 | M. Wt | 634.36 |
Description | Ensartinib, also known as X-396, is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion proteins and ALK point mutation variants. Inhibition of ALK leads to the disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-expressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. | ||
Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
Targets | c Met ALK |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.